This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-surprise: Archive
Texas Roadhouse (TXRH) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Texas Roadhouse (TXRH) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
TXRHNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Live Nation (LYV) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Live Nation (LYV) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
LYVPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
EOG Resources (EOG) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for EOG Resources (EOG) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
EOGNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Solventum (SOLV) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
SOLVNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Maplebear (CART) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Maplebear (CART) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CARTNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Diodes (DIOD) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Diodes (DIOD) delivered earnings and revenue surprises of +33.33% and +3.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DIODPositive Net Change PXLWNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Guild Holdings Company (GHLD) Q2 Earnings Top Estimates
by Zacks Equity Research
Guild (GHLD) delivered earnings and revenue surprises of +53.49% and -3.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GHLDNegative Net Change MRXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Mach Natural Resources LP (MNR) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Mach Natural Resources LP (MNR) delivered earnings and revenue surprises of +43.40% and +18.65%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MNRNegative Net Change KGEINo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
scPharmaceuticals (SCPH) delivered earnings and revenue surprises of -13.33% and -2.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SCPHPositive Net Change CUEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
GoDaddy (GDDY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for GoDaddy (GDDY) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
GDDYNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
PTC Therapeutics (PTCT) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for PTC Therapeutics (PTCT) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
PTCTNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Microchip Tech (MCHP) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Microchip Tech (MCHP) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MCHPNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Here's What Key Metrics Tell Us About Expedia (EXPE) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Expedia (EXPE) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
EXPENegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Puma Biotech (PBYI) delivered earnings and revenue surprises of +36.36% and +4.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PBYIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
ePlus (PLUS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
ePlus (PLUS) delivered earnings and revenue surprises of +13.51% and +23.34%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PLUSNegative Net Change SNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Take-Two Interactive (TTWO) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Take-Two (TTWO) delivered earnings and revenue surprises of +125.93% and +10.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TTWONegative Net Change PVHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Celldex (CLDX) delivered earnings and revenue surprises of +1.16% and -56.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CLDXPositive Net Change YMABNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
CRINETICS PHARM (CRNX) delivered earnings and revenue surprises of -8.85% and -79.78%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CRNXPositive Net Change CASINo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Integral Ad Science (IAS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Integral Ad Science (IAS) delivered earnings and revenue surprises of +75.00% and +3.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IASPositive Net Change BNZINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Kratos (KTOS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Kratos (KTOS) delivered earnings and revenue surprises of +22.22% and +14.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KTOSPositive Net Change ESLTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
OptimizeRx (OPRX) delivered earnings and revenue surprises of +700.00% and +30.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
OPRXPositive Net Change SPNSNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Alta Equipment (ALTG) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Alta Equipment (ALTG) delivered earnings and revenue surprises of +22.22% and +0.81%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ALTGNegative Net Change BWENNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Sutro Biopharma (STRO) delivered earnings and revenue surprises of +64.10% and +293.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
STRONegative Net Change ANIPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TripAdvisor (TRIP) Q2 Earnings Top Estimates
by Zacks Equity Research
TripAdvisor (TRIP) delivered earnings and revenue surprises of +9.52% and -0.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TRIPNegative Net Change FGIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Dropbox (DBX) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Dropbox (DBX) delivered earnings and revenue surprises of +12.70% and +1.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DBXNegative Net Change BLINNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank